Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global PerspectiveMarcie Tomblyn, Michael Boeckh|Biology of Blood and Marrow Transplantation|2009Cited by 1.8k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell TransplantationFrancisco M. Marty, Cyrus Badshah, Randi Y. Leavitt et al.|New England Journal of Medicine|2017Cited by 1.2k
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantationJohn R. Wingard, Kieren A. Marr, Shelly L. Carter et al.|Blood|2010Cited by 477
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplantsKieren A. Marr, Lawrence Corey, Fulvio Crippa et al.|Blood|2003Cited by 442
Preventing Opportunistic Infections After Hematopoietic Stem Cell Transplantation: The Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and BeyondKM Sullivan, K. A. Sepkowitz, Clare A. Dykewicz et al.|Hematology|2001Cited by 164